Sudbo: repeat offender

It looks like Norwegian researcher Jon Sudbo, who hit the headlines earlier this year for linkurl:fabricating;http://www.the-scientist.com/news/display/22952/ data for a Lancet paper has been at the data fraud game for quite some time. That?s the conclusion of a report made public on Friday by a commission set up to probe his research career. The commission members found that most of his 38 scientific publications were riddled with manipulation and fabrication of raw data. Even his doctoral dis

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
It looks like Norwegian researcher Jon Sudbo, who hit the headlines earlier this year for linkurl:fabricating;http://www.the-scientist.com/news/display/22952/ data for a Lancet paper has been at the data fraud game for quite some time. That?s the conclusion of a report made public on Friday by a commission set up to probe his research career. The commission members found that most of his 38 scientific publications were riddled with manipulation and fabrication of raw data. Even his doctoral dissertation is going to be rescinded, not to mention a number of his later works. The 147-page report criticizes the University of Oslo and the Rikshospitalet-Radiumhospitalet Medical Center at which Sudbo worked. Commission chair Anders Ekbom and his colleagues apparently believe Sudbo worked alone. They found no evidence that any of his co-authors or colleagues were party to the deceit. The hospital?s strategy director Stein Vaaler took it on the chin. "No one can fail to understand that the fabrication of research data is a bitter pill to swallow for the country's leading research hospital," he said. "We are grateful for the report and accept its conclusions. Now we will do everything in our power to learn from the criticism. We intend to roll up our sleeves and turn this situation into something that will eventually be positive for the hospital and for all medical research." Exactly what the future holds for Sudbo himself is unclear. Apparently, Norwegian authorities are considering striking him from the medical and dental registers. He has resigned from the university and is on sick leave from the hospital, AP reports.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Pincock

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo